Exact Mass: 429.09292639999995

Exact Mass Matches: 429.09292639999995

Found 26 metabolites which its exact mass value is equals to given mass value 429.09292639999995, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Besifloxacin HCl

Besifloxacin Hydrochloride

C19H22Cl2FN3O3 (429.1022174)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

Sulfamethoxazole N1-glucuronide

3,4,5-Trihydroxy-6-[N-(5-methyl-1,2-oxazol-3-yl)4-aminobenzenesulphonamido]oxane-2-carboxylic acid

C16H19N3O9S (429.0841964)


Sulfamethoxazole N1-glucuronide is a metabolite of Sulfamethoxazole. Sulfamethoxazole n1-glucuronide belongs to the family of Phenols and Derivatives. These are compounds containing a phenol moiety, which is a benzene bearing an hydroxyl group.

   
   

SMZ-PtO

SMZ-PtO

C17H15N7O5S (429.08553400000005)


CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); ALGAE_TP_ID 3103 ALGAE_TP_ID 3103; CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b)

   

Sulfamethoxazole glucuronide

1-[(4-amino-benzenesulfonyl)-(5-methyl-isoxazol-3-yl)-amino]-ξ-D-1-deoxy-glucopyranuronic acid

C16H19N3O9S (429.0841964)


   

Sulfamethoxazole N glucuronide

Sulfamethoxazole N glucuronide

C16H19N3O9S (429.0841964)


   

(2-DIMETHYLAMINO-4-NITROPHENYL) PHOSPHORIC ACID DIAMMONIUM SALT MONOHYDRATE

(2-DIMETHYLAMINO-4-NITROPHENYL) PHOSPHORIC ACID DIAMMONIUM SALT MONOHYDRATE

C8H25N5O11P2 (429.10257599999994)


   

N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide

N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide

C23H15N3O6 (429.096081)


   

Bis(4-tert-butylphenyl)iodonium chloride

Bis(4-tert-butylphenyl)iodonium chloride

C20H27ClI+ (429.0845942)


   

Anthrimide

1,1-Iminodianthra-9,10-quinone

C28H15NO4 (429.10010300000005)


   

3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile

3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile

C19H19N5O3S2 (429.09292639999995)


   

resorcin blue, pure

resorcin blue, pure

C24H15NO7 (429.084848)


   

Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)

Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)

C13H31Cl2NO6P2 (429.1003586)


   

(alphaZ)-5-Amino-alpha-[(triphenylmethoxy)imino]-1,2,4-thiadiazole-3-acetic acid ion(1-)

(alphaZ)-5-Amino-alpha-[(triphenylmethoxy)imino]-1,2,4-thiadiazole-3-acetic acid ion(1-)

C23H17N4O3S (429.10213120000003)


   

4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

C18H19ClF3N5S (429.10017200000004)


   

2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone

2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone

C19H19N5O3S2 (429.09292639999995)


   

(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid

(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid

C19H19N5O3S2 (429.09292639999995)


   

N-acetyl-L-aspartyl-L-glutamyl-L-glutamate

N-acetyl-L-aspartyl-L-glutamyl-L-glutamate

C16H19N3O11-4 (429.10195439999995)


   

3-(2-Benzo[1,3]dioxol-5-yl-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl)-benzonitrile

3-(2-Benzo[1,3]dioxol-5-yl-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl)-benzonitrile

C24H15NO7 (429.084848)


   

N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide

N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide

C21H20ClN3O3S (429.09138400000006)


   

4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide

4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide

C21H20ClN3O3S (429.09138400000006)


   

2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide

2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide

C23H16ClN5O2 (429.0992466)


   

Sulfamethoxazole N1-glucuronide

1-[(4-amino-benzenesulfonyl)-(5-methyl-isoxazol-3-yl)-amino]-ξ-D-1-deoxy-glucopyranuronic acid

C16H19N3O9S (429.0841964)


   

UBP316

UBP316

C20H19N3O6S (429.0994514000001)


UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist[1].